ICON Announces Results of Annual General Meeting Read more about ICON Announces Results of Annual General Meeting
ICON’s Leadership and Performance in Phase 1 Clinical Trials Recognised in Independent Industry Benchmarking Report Read more about ICON’s Leadership and Performance in Phase 1 Clinical Trials Recognised in Independent Industry Benchmarking Report
ICON and Its Employees Recognised as Clinical Research Industry Leaders, and for Innovation and Progress in Sustainability Read more about ICON and Its Employees Recognised as Clinical Research Industry Leaders, and for Innovation and Progress in Sustainability
ICON plc Schedules Second Quarter 2025 Earnings Conference Call Read more about ICON plc Schedules Second Quarter 2025 Earnings Conference Call
ICON plc to Present at the William Blair 45th Annual Growth Stock Conference Read more about ICON plc to Present at the William Blair 45th Annual Growth Stock Conference
Global ICON survey shows need for more efficient obesity clinical trial design to realise full potential of next-gen multi-indication therapies Read more about Global ICON survey shows need for more efficient obesity clinical trial design to realise full potential of next-gen multi-indication therapies
ICON plc Schedules First Quarter 2025 Earnings Conference Call Read more about ICON plc Schedules First Quarter 2025 Earnings Conference Call
